Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05695430 · ClinicalTrials.gov registry record · NA

Brief Cognitive Behavioral Therapy for People With Physical Disabilities

A NA study of Suicide and Suicidal Ideation, sponsored by Ohio State University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT05695430 is a NA study of Suicide and Suicidal Ideation that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 60 participants, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05695430, a NA study of Suicide and Suicidal Ideation, is actively recruiting participants, sponsored by Ohio State University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine the effectiveness of a psychotherapy (non-medication) treatment, Brief Cognitive Behavioral Therapy for Suicide Prevention, in reducing suicide ideation and attempts for people with physical disabilities.

Interventions

  • BEHAVIORAL Brief Cognitive Behavioral Therapy for People with Physical Disabilities

Study Locations (1)

Ohio

  • The Ohio State Universitty Wexner Medical Center - Columbus

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2022-03-01
Est. Completion 2026-03
Phase NA

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT05695430

The ClinicalTrials.gov registry entry for NCT05695430 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Suicide appearing as the primary indexed condition, and to 1 intervention - of which Brief Cognitive Behavioral Therapy for People with Physical Disabilities is the first listed.

NCT05695430 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05695430 about?

NCT05695430 is a clinical study titled "Brief Cognitive Behavioral Therapy for People With Physical Disabilities". The purpose of this study is to examine the effectiveness of a psychotherapy (non-medication) treatment, Brief Cognitive Behavioral Therapy for Suicide Prevention, in reducing suicide ideation and attempts for people with physical disabilities.

What is the current status of trial NCT05695430?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2022-03-01. Estimated completion is 2026-03.

What conditions does trial NCT05695430 study?

This clinical trial studies the following conditions: Suicide, Suicidal Ideation, Suicide, Attempted, Disability Physical, Disability Hearing.

What interventions are being tested in trial NCT05695430?

The interventions under investigation include: Brief Cognitive Behavioral Therapy for People with Physical Disabilities (BEHAVIORAL).

Who is sponsoring clinical trial NCT05695430?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05695430 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.